Autologous stem cell transplantation in acute myelocytic leukemia

Blood

Volumn 92, Issue 4, 1998, Pages 1073-1090

  Gorin, N C ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; AMSACRINE; ANTINEOPLASTIC AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MAFOSFAMIDE; MELPHALAN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BONE MARROW PURGING; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CRYOPRESERVATION; CYTOMEGALOVIRUS INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVER VENOOCCLUSIVE DISEASE; LUNG ASPERGILLOSIS; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; SEPSIS; WHOLE BODY RADIATION;

EID: 0032529505     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1073     Document Type: Review

References (167)

1. Barnes DWH, Loutit JF: Radiation recovery factor and preservation by the Polge Smith Parkes technique. J Natl Cancer Inst 15:1901, 1955
2. Polge C, Smith AU, Parkes AS: revival of spermatozoa after vitrification and dehydratation at low temperatures. Nature 164:666, 1949
3. Gorin NC, Bull MI, Herzig GP, Graw RG: Long term preservation of bone marrow for autologous bone marrow transplantation. Clin Res 23:338a, 1975
4. Douay L, Gorin NC, David R, Stachowiak J, Salmon CH, Najman A, Duhamel G: Study of granulocyte-macrophage progenitor (CFUc) preservation after slow freezing of bone marrow in the gas phase of liquid nitrogen. Exp Hematol 10:360, 1982
5. Gorin NC, Douay L, David R, Stachowiak J, Parlier Y, Oppenheimer M, Najman A, Duhamel G: Delayed kinetics of recovery of hematopoiesis following autologous bone marrow transplantation: The role of excessively rapid marrow freezing rates after the release of fusion heat. Eur J Cancer 19:485, 1983
6. Gorin NC: Collection, manipulation and freezing of haemopoietic stem cells. Clin Haematol 15:19, 1986
7. Douay L, Lopez M, Gorin NC: A technical bias: Differences in cooling rates prevent ampoules from being areliable index of stem cell cryopreservation in large volumes. Cryobiology 23:296, 1986
8. Ashwood-Smith MJ: Preservation of mouse bone marrow at -79 with dimethylsulphoxide. Nature 190:1204, 1961
9. Porter KA, Murray JE: Successful homotransplantation of rabbit bone marrow after preservation in glycerol at -70. Cancer Res 18:117, 1958
10. Buckner D, Storb R, Dilligham LA, Thomas ED: Low temperature preservation of monkey marrow in DMSO. Cryobiology 7:136, 1970
11. Schaefer UW, Dicke KA, Van Bekkum DW: Recovery of hematopoiesis in lethally irradiated monkeys by frozen allogeneic bone marrow grafts. Rev Eur Clin Biol 17:483, 1972
12. Cavins JA, Scheer SC, Thomas ED, Ferrebee JW: The recovery of lethally irradiated dogs given infusions of autologous marrow stored at low temperatures in DMSO. Blood 20:730, 1962
13. Epstein RB, Storb R, Clift RA, Thomas ED: Autologous bone marrow grafts in dogs treated with lethal doses of cyclophosphamide. Cancer Res 29:1072, 1969
14. Gorin NC, Herzig G, Bull MI, Graw RG: Long term preservation of bone marrow and stem cell pool in dogs. Blood 51:257, 1978
15. Appelbaum FR, Herzig GP, Graw RG, Bull MI, Bowles C, Gorin NC, Deisseroth A: Study of cell dose and storage time on engraftment of cryopreserved autologous bone marrow in a canine model. Transplantation 26:245, 1978
16. Gorin NC, Najman A, Duhamel G: Autologous bone marrow transplantation in acute myelocytic leukemia. Lancet 1:1050, 1977
17. Appelbaum FR, Herzig GP, Ziegler JL, Graw RGG, Levine AS, Deisseroth AB: Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 52:85, 1978
18. Dicke KA, Spitzer G, Peters L, Mac Credie KC, Zander A, Verma DS, Vellekoop L, Hester J: Autologous bone marrow transplantation in relapsed adult acute Leukemia. Lancet 1:514, 1979
19. Gorin NC, David R, Stachowiak J, Salmon C, Petit JC, Parker Y, Najman A, Duhamel G: High dose chemotherapy and autologous bone marrow transplantation in acute leukemias,malignant lymphomas and solid tumors. A study of 23 patients. Eur J Cancer 17:557, 1981
20. Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neuman PE, Sale GE, Sanders JE, Sunger JW, Shulman H, Storb R, Weiden PL: Marrow transplantation for acute non lymphoblastic leukemia in first remission. N Engl J Med 301:597, 1979
21. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft versus leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
22. Dexter TM, Chang J: New strategies for the treatment of chronic myeloid leukemia. Blood 84:673, 1994
23. Dusenbery KE, Steinbuch M, McGlave PB, Ramsay NK, Blazar BR, Neglia JP, Litz C, Kersey JH, Woods WG: Autologous bone marrow transplantation in acute myeloid leukemia: The University of Minnesota experience. Int J Radiat Oncol Biol Phys 36:335, 1996
24. Korbling M, Hunstein W, Fliedner TM, Cayeux S, Dorken B, Fehrentz D, Haas R, Ho AD, Keilholz U, Kneuf W, Konig A, Mende U, PezWolf G, Kzuto A, Wannenmacher M, zum Winkel K, Rother K: Disease free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia. Blood 74:1898, 1989
25. Rizzoli V, Carlo-Stella C: Stem cell purging: An intriguing dilemma. Exp Hematol 23:296, 1995
26. Cassileth PA, Andersen J, Lazarus HM, Colvin OM, Bennett JM, Stadtmauer EA, Kaizer H, Weiner RS, Edelstein M, Oken MM: Autologous bone marrow transplant in acute myeloid leukemia in first remission. J Clin Oncol 11:314, 1993
27. Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL: Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen. Blood 81:311, 1993
28. Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL: Autologous bone marrow transplantation for acute myeloid leukemia using 4 Hydroperoxycyclosphosphamide purged bone marrow and the busulfanetoposide preparative regimen: A follow up report. (submitted)
29. Gorin NC, Douay L, Laporte JP, Lopez M, Mary JY, Najman A, Salmon C, Aegerter P, Stachowiak J, David R, Pene F, Kankor G, Deloux J, Duhamel E, van den Akker J, Gerota Y, Parker Y, Duhamel G: Autologous bone marrow transplantation using marrow incubated with ASTA-Z 7557 in adult acute leukemia. Blood 67:1367, 1986
30. Laporte JP, Douay L, Lopez M, Labopin M, Jouet JP, Lesage S, Stachowiak J, Fouillard L, Isnard F, Noel-Walter MP, Pene F, Deloux J, Van Den Akker J, Grande M, Bauters F, Najman A, Gorin NC: One hundred twenty five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide. A 10 year single institution experience. Blood 84:3810, 1994
31. Gulati S, Acaba L, Yalahom J, Reich L, Motzer R, Crown J, Doherty M, Clarkson B, Berman E, Atzpodien J, Andreeff M, Gee T: Autologous bone marrow transplantation for acute myelogenous leukemia, using 4 hydroperoxycyclophosphamide and VP-16 purged bone marrow. Bone Marrow Transplant 10:129, 1992
32. Woods WG, Kobrinsky N, Buckley J, Neudorf S, Sanders J, Miller L, Barnard D, Benjamin D, DeSwarte J, Kalousek D, Shuna D, Hanunond G, Lange BJ: Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Childrens Cancer Group pilot study. J Clin Oncol 11:1448, 1993
33. Selvaggi KJ, Wilson JW, Mills LE, Corwell GG, Hurd D, Dodge W, Gingrich R, Martin SE, McMillan R, Miller W, Ball ED: Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow. Blood 83:1698, 1994
34. Ball ED, Phelps V, Wilson J: Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow. Blood 88:485a, 1996 (abstr, suppl 1)
35. Yeager AM, Kaizer H, Santos GW, Saral R, Colvin ON, Stuart RK, Brain HG, Burke PJ, Ambinder RF, Burns WH, Fuller DJ, Davis JM, Karp JE, May WS, Rowley SD, Sensenbrenner LL, Vogelsang GB, Wingard JR: Autologous bone marrow transplantation in patients with acute non lymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. NEngl J Med 315:141, 1986
36. Yeager AM: Autologous bone marrow transplantation for acute myeloid leukemia, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Oxford, UK, Blackwell Scientific, 1994, p 709
37. Carella AM, Gaozza E, Santini G, Martinengo M, Pungolino E, Piatti G, Congiu A, Nati S, Carlier P, Giordano D, Cerri R, Risso M, Miceli S, Raffo MR, Scarpati D, Corvo R, Franzone P, Vitale V, Vimercati AR, D'Amico T, Marmont A: Autologous unpurged bone marrow transplantation for acute non lymphoblastic leukaemia in first remission. Bone Marrow Transplant 3:537, 1988
38. Dicke K, Jagannath S, Walters RS, Horwitz LJ, Spitzer G: The role of autologous bone marrow transplantation in acute leukemia. Ann NY Acad Sci 511:468, 1987
39. Mc Millan AK, Goldstone AH, Linch DC, Gribben JG, Patterson KG, Richards JDM, Franklin I, Boughton BJ, Milligan DW, Leyland M, Hutchison RM, Newland AC: High dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemia. Blood 76:480, 1990
40. Wahlin A, Brinch L, Hornsten P, Evensen SA, Oberg G, Simonsson B, Hedenus M: Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia. Eur J Haematol 58:233, 1997
41. Stein AS, O'Donnell MR, Chai A, Schmidt GM, Nademanee A, Parker PM, Smith EP, Snyder DS, Molina A, Stepan DE, Spielberger R, Somlo G, Margolin KA, Vora N, Lipsett J, Lee J, Niland J, Forman SJ: In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. J Clin Oncol 14:2206, 1996
42. Miggiano MC, Gherlinzoni F, Rosti G, Bandini G, Visani G, Fiacchini M, Ricci P, Testoni N, Motta MR, Geromin A, Rizzi S, Belardinelli A, Mangianti S, Manfroi S, Tura S: Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia. Leukemia 10:402, 1996
43. Meloni G, De Fabritiis P, Carella AM, Mangoni L, Porcellini A, Marmont A, Mandelli F: Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapy. Bone Marrow Transplant 5:29, 1990
44. Sierra J, Granena A, Garcia J, Valls A, Carreras E, Rovira M, Canals C, Martinez E, Punti C, Algara M, Marin P, Meruno A, Terop MJ, Urbano-Ispizua A, Rozman C: Autologous bone marrow transplantation for acute leukemia: Results and prognostic factors in 90 consecutive patients. Bone Marrow Transplant 12:517, 1993
45. Tomas JF, Gomez Garcia de Soria V, Pinilla I, Lamana M, Figuera A, Arranz R, Camara R, Fernandez Villalta MJ, Alegre A, Fernandez Ranada JM: Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients. Med Clin Bare 108:201, 1997
46. Mehta J, Powles R, Singhal S, Horton C, Tait D, Milan S, Meller S, Pinkerton CR, Treleaven J: Autologous bone marrow transplantation for acute myeloid leukemia in first remission: Identification of modifiable prognostic factors. Bone Marrow Transplant 16:499, 1995
47. Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou Bourdeau H, Gluckman E: Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 18:111, 1996
48. Meloni G, Vignetti M, Avvisati G, Capria S, Micozzi A, Giona F, Mandelli F: BAVC regimen and autograft for acute myelogenous leukemia in second complete remission. Bone Marrow Transplant 18:693, 1996
49. Tomas F, Gomez Garcia de Soria V, Lopez Lorenzo JL, Arranz R, Figuera A, Camara R, Alegre A, Fernandez Ranada JM: Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission. Importance of duration of first complete remission in final outcome. Bone Marrow Transplant 17:979, 1996
50. Tiedemann K, Waters KD, Tauro GP, Tucker D, Ekert H: Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission. Blood 82:3730, 1993
51. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993
52. To LB, Juttner CA: Peripheral blood stem cell autografting: A new therapeutic option for AML? Br J Haematol 66:285, 1987
53. Reiffers J, Bernard P, David B, Vezon G, Sarrat A, Marit G, Moulinier J, Broustet A: Successful autologous transplantation with peripheral blood in a patient with acute leukaemia. Exp Hematol 14:312, 1986
54. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994
55. Mehta J, Powles R, Singhal S, Treleaven J: Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant 15:652, 1995
56. Petersen FB, Lynch MH, Clift RA, Appelbaum FR, Sanders JE, Bensinger WI, Benyunes MC, Doney K, Fefer A, Martin P, Storb R, Rowley S, Sullivan KM, Witherspoon R, Weiden R, Thomas ED, Fisher L, Hansen JA, Buckner CD: Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. J Clin Oncol 11:1353, 1993
57. Schiffman K, Clift R, Appelbaum FR, Sanders J, Bensinger W, Petersen FB, Rowley S, Hill R, Martin P, Storb R, Weiden P, Thomas ED, Hansen JA: Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia. Bone Marrow Transplant 11:227, 1993
58. Grimwade D, Walker H, Oliver F, Wheathley K, Clack R, Burnett A, Goldstone A: What happens subsequently in AML, when cytogenetic abnormalities persist at bone marrow harvest? Results of the tenth UK MRC AML trial. Bone Marrow Transplant 19:1127, 1997
59. Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H, Mellits D, Sensenbrenner LL, Stuart RK, Yeager AM: Marrow transplantation for acute non lymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309:1347, 1983
60. Tutschka PJ, Copelan EA, Klein JP: Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70:1382, 1987
61. Hagenbeek A, Martens ACM: Minimal residual disease in acute leukaemia:preclinical studies in a relevant rat model (BNML), in Jasmin C, Proctor SJ (eds): Baillieres Clinical Haematology. London, UK, Bailliere Tindall, Saunders, 1991, p 609
62. Snyder DS, Chao NJ, Amylon MD, Taguchi J, Long GD, Negrin RS, Nademanee AP, O'Donnell MR, Schmidt GM, Stein AS, Parker PM, Smith EP, Stepan DE, Molina A, Lipsett JA, Hoppe RT, Niland JC, Dagis AC, Wong RM, Forman SJ, Blume KA: Fractionated total body irradiation and high dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 82:2920, 1993
63. Chao NJ, Stein AS, Long GD, Negrin RS, Amylon MD, Wong RM, Forman SJ, Blume KG: Busulfan etoposide,initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute non lymphocytic leukemia. Blood 81:319, 1993
64. Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Camitta B, Weinstein HJ: Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric oncology group. N Engl J Med 334:1428, 1996
65. Vignetti M, Rondelli R, Locatelli F, Lanino E, Miniero R, Rossetti F, Meloni G: Autologous bone marrow transplantation in children with acute myeloblastic leukemia: Report from the Italian National Pediatric Registry (AIEOP-BMT). Bone Marrow Transplant 18:59, 1996(suppl2)
66. Klingebiel T, Pession A, Paolucci P, Rondelli R: Autologous versus allogeneic BMT in AML: The European experience. Report of the EBMT-Pediatric Diseases Working Party. Bone Marrow Transplant 18:49, 1996 (suppl 2)
67. Douay L, Laporte JP, Mary JY, Lopez M, Lemonnier MP, Stachowiak J, Benitez O, Deloux J, Najman A, Salmon C, Gorin NC: Differences in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557). Bone Marrow Transplant 2:33, 1987
68. Lowenberg B, Verdonck LJ, Dekker AW, Willemze R, Zwann FE, De Planque M, Abels J, Sonneveld P, Van der Lelie J, Goudsmit R, Van Putten WLJ, Sizoo W, Hagenbeek A, De Gast GC: Autologous bone marrow transplantation in acute myeloid leukemia in first remission: Results of a Dutch Prospective Study. J Clin Oncol 8:287, 1990
69. Rowley SD, Zuehlsdorf M, Braine H, Colvin OM, Davis J, Jones RJ, Saral R, Sensenbrenner LL, Yeager A, Santos GW: CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged bone marrow. Blood 70:271, 1987
70. Carlo-Stella C, Mangoni L: Use of recombinant human granulocyte-macrophage colony stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamidepurged autologous marrow. Blood 80:2412, 1992
71. Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy J, Wiley JM, Wingard JR, Yeager AM, Santos GW: Analysis of factors predicting speed of hematologic recovery after transplantation with 4 hydroperoxycyclophosphamide purged autologous bone marrow grafts. Bone Marrow Transplant 7:183, 1991
72. Visani G, Dinota A, Tosi P, Verlicchi F, Motta MR, Rizzi S, Colombini R, Cenacchi A, Fogli M, Lemoli RM, Ricci P, Albertazzi L, Bandini G, Tura S: Cryopreserved autologous bone marrow transplantation in patients with acute non lymphoid leukemia:chemotherapy before harvesting is the main factor in delaying hematologcal recovery. Cryobiology 27:103, 1990
73. Douay L, Gorin NC, Mary JY, Lemarie E, Lopez M, Najman A, Stachowiak J, Giarratana MC, Baillou C, Salmon C, Duhamel G: Recovery of CFUGM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 14:358, 1986
74. Esteve J, Sierra J, Marin E, Carreras E, Rovira M, Merino A, Urbano-Ispuiza A, Rozman C, Montserrat E: Poor hematological reconstitution but good outcome following autologous transplantation using unpurged marrow collected after intermediate or high dose ARA-C. Haematologica 82:67, 1997 (suppl 1)
75. Burnett AK, Graham S, Alcorn M: Sustained growth in long term bone marrow culture of AML remission marrow predicts a high probability of remaining relapse free after auto BMT in first complete remission. Exp Hematol 21:1020a, 1993
76. Straetmans N, Ma DDF, Herman P, Zenebergh A, Chang A, Deneys V, De Bruyere M, Ferrant A: Long term culture of autologous transplanted bone marrow for acute myeloid leukaemia: Evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment. Bone Marrow Transplant 15:421, 1995
77. Nemunaitis J, Appelbaum FR, Lilleby K, Buhles WC, Rosenfeld C, Zeigler ZR, Shadduck RK, Singer JW, Meyer W, Buckner CD: Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia. Blood 83:3473, 1994
78. Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard Zollinger L, Keating A: Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Exp Hematol 21:405, 1993
79. Shpall EJ, Stemmer SM, Hami L, Franklin WA, Shaw L, Bonner HS, Bearman SI, Peters WP, Bast RC, McCulloch W, Capizzi R, Mitchell E, Schein PS, Jones RB: Amifostine (WR-2721) shortens the engraftment period of 4-Hydroperoxycyclophosphamide purged bone marrow in breast cancer patients receiving high dose chemotherapy with autologous bone marrow support. Blood 83:3231, 1994
80. Sanz MA, de la Rubia J, Sanz GF, Martin G, Martinez J, Jarque I, Sempere A, Gomis F, Senent L, Soler MA, Lopez F, Arilla MJ, Carpio N, Guinot M, Palau J, Tudela M, Marty L: Busulfan plus Cyclophosphamide followed by autologous blood stem cell transplantation for patients with acute myeloblastic leukemia in first complete remission: A report from a single institution. J Clin Oncol 11:1661, 1993
81. Gondo H, Harada M, Miyamoto T, Takenada K, Tanimoto K, Mizuno S, Fujisaki T, Nagafuji K, Hayashi S, Eto T, Taniguchi S, Akashi K, Harada N, Yamasaki K, Shibuya T, Matsuishi E, Ohno Y, Makino S, Takamatsu Y, Murakawa M, Teshima T, Hirota Y, Okamura T, Kinukawa N, Inaba S, Niho Y: Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia. Bone Marrow Transplant 20:821, 1997
82. Laporte JP, Gorin NC, Feuchtenbaum J, Lopez M, Douay L, Lyon-Caen D, Du Puy Montbrun MC, Lemonnier MP, Isnard F, Najman A: Relapse after autografting with peripheral blood stem cells. Lancet 2:1393, 1987
83. Testa U, Martucci R, Rutella S, Scambia G, Sica S, Benedetti Panici P, Pierelli L, Menichella G, Leone G, Mancuso S, Peschle C: Autologous stem cell transplantation: Release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood 84:3532, 1994
84. Cahn JY, Labopin M, Mandelli F, Goldstone AH, Eberhardt K, Reiffers J, Ferrant A, Franklin I, Herve P, Gratwohl A, Gorin NC: Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in elderly patients: A retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT). Blood 85:575, 1995
85. Gorin NC, Labopin M, Meloni G, Korbling M, Carella A, Herve P, Burnett A, Rizzoli V, Alessandrino EP, Bjorkstrand B, Ferrant A, Lowenberg B, Coser P, Simonsson B, Heibig W, Brunet Mauri S, Verdonck LF, Iriondo A, Polli E, Colombat P, Franklin IM, Souillet G, Willemze R: Autologous bone marrow transplantation for acute myelocytic leukemia in Europe: Further evidence of the role of marrow purging by mafosfamide. Leukemia 5:896, 1991
86. Ferrant A, Labopin M, Frassoni F, Prentice HG, Cahn JY, Biaise D, Reiffers J, Visani G, Sanz MA, Boogaerts MA, Lowenberg B, Gorin NC: Karyotype in acute mtyeioblastic leukemia (AML): Prognostic significance for bone marrow transplantation in first remission. An EBMT Study. Blood 90:2931, 1997
87. Ringden O, Labopin M, Tura S, Arcese W, Iriondo A, Zittoun R, Sierra J, Gorin NC: A comparison of busulfan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Br J Haematol 93:637, 1996
88. Dusenbery KE, Daniels KA, McClure JS, McGlave PB, Ramsay NK, Blazar BR, Neglia JP, Kersey JH, Woods WG: Randomized comparison of cyclophosphamide-total body irradiation versus busulfancyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. Int J Radiat Oncol Biol Physiol 31:119, 1995
89. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E III, for the Cancer and Leukemia Group B: Intensive post remission chemotherapy in adults with acute myeloid leukemia. N EngI J Med 331:896, 1997
90. Cahn JY, Labopin M, Gorin NC, on behalf of EBMT: Impact of cytosine-arabinoside (ARA-C) dose given at induction ± consolidation before allogeneic or autologous stem cell transplantation (SCT) for acute myeloblastic leukemia in first remission. Blood 90:228a, 1997 (abstr, suppl 1)
91. Frassoni F, Labopin M, Gluckman E, Prentice HG, Gahrton G, Mandelli F, Carella AM, Herve P, Gratwohl A, Goldman J, Gorin NC, for the Acute Leukemia Working Party of the EBMT: Are patients with acute leukemia alive and well 2 years post bone marrow transplantation cured? A European survey. Leukemia 8:924, 1994
92. Gorin NC, Aegerter P, Auvert B, Meloni G, Goldstone AH, Burnett A, Carella A, Korbling M, Herve P, Maraninchi D, Lowenberg R, Verdonck LF, De Planque M, Hermans J, Helbig W, Porcellini A, Rizzoli V, Alesandrino EP, Franklin IM, Reiffers J, Colleselli P, Goldman JM: Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: A European survey of the role of marrow purging. Blood 75:1606, 1990
93. Dann EJ, Gillis S, Rowe JM: Late relapse following autologous bone marrow transplantation for acute myelogenous leukemia: Case report and review of the literature. Leukemia 9:1072, 1995
94. Gribben JG, Arnold MD, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
95. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson F, Hester J, Korbling M, Durett A, Moen R, Berenson R, Heimfeld S, Harmer J, Calvert L, Tibbits P, Talpaz M, Kantarjian H, Champlin R, Reading C: Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplantation in CML. Blood 83:3068, 1994
96. Sharkis SJ, Santos GW, Colvin OM: Elimination of acute myelogenous leukemia cells from marrow and tumor suspensions in the rat with 4 hydroperoxycyclophosphamide. Blood 55:521, 1980
97. Schultz FW, Martens ACM, Hagenbeek A: The contribution of residual leukemic cells in the graft to leukemia relapse after autologous bone marrow transplantation: Mathematical considerations. Leukemia 3:530, 1989
98. Wiley JM, Yeager AM: Predictive value of colony forming unit assays for engraftmem and leukemia free survival after transplantation of chemopurged syngeneic bone marrow in rats. Exp Hematol 19:179, 1991
99. Reading CL, Estey EH, Huh YO, Claxton DF, Sanchez G, Terstappen LW, O'Brien MC, Baron S, Deisseroth AB: Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood 81:3083, 1993
100. San Miguel JF, Martinez A, Macedo A, Vidriales MB, Lopez-Berges C, Gonzalez M, Caballero D, Garcia-Marcos MA, Ramos F, Fernandez-Calvo J, Calmuntia MJ, Diaz-Mediavilla J, Orfao A: Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients, Blood 90:2465, 1997
101. Perot C, Van Den Akker J, Laporte JP, Douay L, Lopez M, Stachowiak J, Isnard F, Taillemitte JL, Najman A, Gorin NC: Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide. Leukemia 7:509, 1993
102. Miller CB, Zehnhauser A, Piantadosi S, Rowley SD, Jones RJ: Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation. Blood 78:1125, 1991
103. Tobal K, Liu-Yin JA: Monitoring of minimal residual disease by quantitative reverse transcriptase polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8,21). Blood 88:3704, 1996
104. Mandelli F, Diverio D, Awisati G, Luciano A, Barbui T, Bernasconi C, Lo Coco F: Molecular remission in PML/RAR alpha positive acute promy/ocytic leukemia by combined all-trans reunoic acid and idarubicin (AIDA) Therapy. Blood 90:1014, 1997
105. Meloni G, Diverio D, Vignetti M, Avvisati G, Capria S, Petti MC, Mandelli F, Lo Coco F: Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: Prognostic relevance of pretransplant minimal residual disease assesment by reverse-transcription polymerase chain reaction of the PML-RAR alpha fusion gene. Blood 90:1321, 1997
106. Brenner MK, Rill DR, Moen RC, Krance RA, Heslop HE, Mirro J Jr, Anderson WF, Ihle JN: Gene marking and autologous bone marrow transplantation. Ann NY Acad Sci 716:204, 1994
107. Allieri MA, Lopez M, Douay L, Mary JY, N'Guyen L, Gorin NC: Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: Possible purging effect for autologous bone marrow transplantation. Bone Marrow Transplant 7:101, 1991
108. Verdonck LF, Heesben EC, van Heugten HG, Staal GEJ, Rijksen G: The cytotoxicity of Alkyl-Lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation. Bone Marrow Transplant 9:241, 1992
109. Toren A, Rechavi G: What really cures in autologous bone marrow transplantation? A possible role for Dimethylsulfoxide. Medical Hypotheses 41:495, 1993
110. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 367:645, 1994
111. Skorski T, Kawalek M, Hoser G, Ratajczak M, Gnatowski B, Kawiak J: The kinetics of immunologie and hematologic recovery in mice after letal total body irradiation and reconstitution with syngeneic bone marrow cells treated or untreated with mafosfamide (Asta Z 7654). Bone Marrow Transplant 3:543, 1988
112. Bullock G, Tang C, Tourkina E, Ibrado AM, Lutzky J, Huang Y, Mahoney ME, Bhalla K: Effect of combined treatment with interleukin-3 and interleukin-6 on 4 hydroperoxycyclophosphamide induced programmed cell death or apoptosis in human myeloid leukemia cells. Exp Hematol 21:1640, 1993
113. Almici C, Mangoni L, Carlo-Stella C, Garau D, Cottafavi L, Rizzoli V: Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow. Bone Marrow Transplant 16:95, 1995
114. Rowley SD, Jones RJ, Piantadosi S, Hayden G, Braine O, Colvin M, Davis J, Saral R, Sharkis S, Wingard J, Yeager AM, Santos GW: Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia. Blood 74:501, 1989
115. Lopez M, Dupuy-Montbrun MC, Douay L, Laporte JP, Gorin NC; Standardization and characterization of the procedure for in vitro treatment of human bone marrow with cyclophosphamide derivatives. Clin Lab Haematol 7:327, 1985
116. Douay L, Mary JY, Giarratana MC, Najman A, Gorin NC: Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide(Asta Z 7557). Exp Hematol 17:429, 1989
117. Douay L, Giarratana MC, Labopin M, Bardunet D, Bouchet S, Gorin NC: Characterization of late and early hematopoietic progenitor stem cell sensitivity to mafosfamide. Bone Marrow Transplant 15:769, 1995
118. Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C: Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA matching and marrow cell dose. Blood 89:4226, 1997
119. Giralt S, Escudier S, Kantarjian H, Deisseroth A, Freireich EJ, Anderrson BS, O'Brien S, Andreef M, Fischer H, Cork A, Hirsch-Ginsberg C, Trujillo J, Stass S, Champlin RE: Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. N Engl J Med 329:757, 1993
120. Capizzi RL: Amifostine: The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies. Semin Oncol 23:2, 1996 (suppl 8)
121. Douay L, Hu C, Giarratana MC, Bouchet S, Conlon J, Capizzi RL, Gorin NC: Amifostine improves the antileukemic therapeutic index of mafosfamide: Implications for bone marrow purging. Blood 86:2849, 1995
122. Olivieri A, Poloni A, Montanari M, Canton I, Ombrosi L, Masia MC, Mancini S, Leoni P: Pharmacological bone marrow purging: Is there any place for etoposide? In vitro comparison with mafosfamide. J Hematother 6:137, 1997
123. Vogler WR, Berdel WE: Autologous bone marrow transplantation with alkyllysophospholipid-purged marrow. J Hematother 2:93, 1993
124. Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL: The sensitivity of leukemic bone marrow to Simvastatin is lost at remission: A potential purging agent for autologous bone marrow transplantation. J Invest Med 43:269, 1995
125. Ericson SG, Colby E, Welch L, Ball ED: Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow. Bone Marrow Transplant 9:129, 1992
126. Robertson MJ, Soiffer RJ, Freedman AS, Rabinowe SL, Anderson KC, Ervin TJ, Murray C, Dear K, Griffin JD, Nadler LM, Ritz J: Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: Clinical trial of MY9 monodonal anti body-purged autografts for the treatment of acute myeloid leukemia. Blood 79:2229, 1992
127. Kaneko T, Fusauchi Y, Kakiu Y, Masuda M, Akakoshi M, Teramura M, Motoji T, Okumura K, Mizoguchi H, Oshimi K: A bispecific antibody enhances cytokine
128. Notter M, Ludwig WD, Bremer S, Thiel E: Selective targeting of human lymphokine activated killer cells by CD-3 monoclonal antibody against the interferon inducible high affinity FcγRI receptor (CD64) on autologous acute myeloid leukemic blast cells. Blood 82:3113, 1993
129. Zhong RK, Donnenberg AD, Rubin J, Ball ED: Differential effect of 4-Hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging. Blood 83:2345, 1994
130. Chang J, Morgenstern GR, Countinho L, Scarffe J, Carr T, Deakin DP, Testa NG, Dexter TM: The use of bone marrow cells grown in long term culture for autologous bone marrow transplantation in acute myeloid leukaemia. An update. Bone Marrow Transplant 4:4, 1989
131. Coulombel L, Kalousek DK, Eaves CJ, Gupla CM, Eaves AC: Long term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome positive chronic myelogeneous leukemia. N Engl J Med 308:1493, 1983
132. Charak BS, Malloy B, Agah R, Mazumder A: A novel approach to purging of leukemia by activation of bone marrow with interleukin 2. Bone Marrow Transplant 6:193, 1990
133. Herrmann RP, O'Reilly J, Meyer BF, Lazzaro G: Prompt haemopoietic reconstitution following hyperthermia purged autologous marrow and peripheral blood stem cell transplantation in acute myeloid leukaemia. Bone Marrow Transplant 10:293, 1992
134. Lowdell MW, Ray N, Craston R, Corbett T, Deane M, Prentice HG: The in vitro detection of anti-leukaemia specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia. Bone Marrow Transplant 19:891, 1997
135. Prentice HG, Macdonald ID, Hamon MD: Understanding the mechanism of cure of acute myeloid leukemia by allogeneic bone marrow transplantation: Toward the application of interleukin-2 in autologous bone marrow transplantation. J Hematother 3:47, 1994
136. Benyunes MC, Massumoto C, York A, Higuchi CM, Buckner CD, Thompson JA, Petersen FB, Fefer A: Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant 12:159, 1993
137. Adler A, Chervenick PA, Whiteside T, Lotzova E, Heiberman RB: Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. 1: Feasibility of LAK generation in adult patients with active disease and in remission. Blood 71:709, 1988
138. Meloni G, Foa R, Tosti S, Vignetti M, Mancini F, Guarini A, Marchis D, Gavosto F, Mandelli F: Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: A pilot study. Leukemia 6:780, 1992
139. Yeager AM, Vogelsang GB, Jones RJ, Farmer ER, Altomonte V, Hess AD, Santos GW: Induction of cutaneous graft versus host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood 79:3031, 1992
140. Motta MR, Mangianti S, Rizzi S, Ratta M, Campanini E, Fortuna A, Fogli M, Tura S, Lemoli RM: Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: Preclinical studies. Exp Hematol 25:1261, 1997
141. Sanders JE, Seattle Marrow Transplant Team: The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 28:244, 1991
142. Salooja N, Chatterjee R, McMillan AK, Kelsey SM, Newland AC, Milligan DW, Franklin IM, Hutchinson RM, Linch DC, Goldstone AH: Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol. Bone Marrow Transplant 13:431, 1994
143. Belkacemi Y, Labopin M, Vernant JP, Prentice HG, Tichelli A, Schattenberg A, Boogaerts MA, Ernst P, Della Volpe A, Goldstone AH, Jouet JP, Verdonck LF, Locasciulli A, Rio B, Ozsahin M, Gorin NC: Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: A study of the European Group for Blood and Marrow Transplantation. Int J Rad Oncol Biol Phys 41:659, 1998
144. Van Den Akker J, Gorin NC, Laporte JP, Douay L, Lopez M, Taillemitte JL: Chromosome abnormalities after autologous bone marrow transplantation with marrow treated by cyclophosphamide derivatives. Lancet 1:1211, 1985
145. Shah NK, Wingard JR, Piantadosi S, Rowley S, Santos G, Griffin CA: Chromosome abnormalities in patients treated with 4 hydroperoxy cyclophosphamide purged autologous bone marrow transplantation. Cancer Genet Cytogenet 65:135, 1993
146. Traweek ST, Slovak ML, Nademanee AP, Brynes RK, Niland JC, Forman SJ: Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 84:957, 1994
147. Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weisdorf DJ: Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy. Blood 83:3780, 1994
148. Whitlock JA, Greer JP, Lukens JN: Epipodophyllotoxin-related leukemia: Identification of a new subset of secondary leukemia. Cancer 68:600, 1991
149. Mandelli F, Labopin M, Granena A, Iriondo A, Frassoni FG, Gratwohl A, Gorin NC, EBMT: European survey of bone marrow transplantation in acute promyelocytic leukemia. Bone Marrow Transplant 14:293, 1994
150. Fenaux P, Le Deley M, Castaignes S, Archimbaud E, Chomienne C, Duarte M, Daniel M, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz M, Lowenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Gansr A, Jacky E, Dombret H, Chastang C, Degos L, European APL 91 Group: Effect of all trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Blood 82:341, 1993
151. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ohno R, Japan Acute Leukemia Study Group: All trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85:1202, 1995
152. Degos L, Dombret H, Chomienne C, Daniel M, Miclea J, Chastang C, Castaignes S, Fenaux P: All trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
153. Hermans J, Suciu S, Stynen Th: Treatment of acute myelogeneous leukemia: An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer 25:545, 1989
154. Carella AM, Frassoni F, van Lint MT, Gualandi F, Occhini D, Carlier P, Pollicardo N, Pungolino E, Fagioli F, Santini G: Autologous and allogeneic bone marrow transplantation in acute myeloid leukemia in first complete remission: An update of the Genoa experience with 159 patients. Ann Hematol 64:128, 1992
155. Ringden O, Labopin M, Gluckman E, Hows JM, Bradley BA, Kolb HJ, Fouillard L, Jacobsen N, Vernant JP, Witz F, Harousseau JL, Gorin NC, Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study: Donor search or auto grafting in patients with acute leukaemia who lack an HLA identical sibling? A matched pair-analysis. Bone Marrow Transplant 19:963, 1997
156. Busca A, Anasetti C, Anderson G, Appelbaum FR, Buckner CD, Doney K, Martin PJ, Petersdorf E, Sanders JE, Hansen JA: Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Blood 83:3077, 1994
157. Sierra J, Brunet S, Granena A, Olive T, Bueno J, Ribera JM, Petit J, Besses C, Liorente A, Guardia R, Macia J, Rovira M, Badel I, Vela E, Diaz De Heredia C, Vivancos P, Carreras E, Feliu E, Montserrat E, Julia A, Cubells J, Rozman C, Domingo A, Ortega JJ: Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan group for bone marrow transplantation. J Clin Oncol 14:1353, 1996
158. Reiffers J, Stoppa AM, Attal M, Michallet M, Marit G, Biaise D, Huguet F, Corront B, Cony-Makhoul P, Gastaut JA, Laurent G, Molina L, Braustet A, Maraninchi D, Pris J, Hollard D, Faberes C, for the EBMT Group: Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: The BGMT 87 study. Leukemia 10:1874, 1996
159. Mitus AJ, Miller KB, Schenkein DP, Ryan HF, Parsons SK, Wheeler C, Antin JH: Improved survival for patients with acute myelogenous leukemia. J Clin Oncol 13:560, 1995
160. Harousseau JL, Cahn JY, Pignon B, Witz F, Milpied N, Detain M, Lioure B, Lamy T, Desablens B, Guilhot F, Caillot D, Abgrall JF, François S, Briere J, Guyotat D, Casassus P, Audhuy B, Tellier Z, Hurteloup P, Herve P, for the Groupe Ouest Est Leucémies Aiguës Myeloblastiques (GOELAM): Comparison of autologous bone marrow transplantation and intensive chemotherapy as post remission therapy in adult acute myeloid leukemia. Blood 90:2978, 1997
161. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Stryckmans P, Rotoli B, Leoni P, Peetermans ME, Dardenne M, Vegina ML, Petti MC, Solbu G, Sucin S, for the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 332:217, 1995
162. Cassileth PA, Andersen JW, Bennett JM, Harrington DP, Hines JD, Lazarus HM, Mazza JJ, McGlave PP, O'Connell MJ, Paietta E: Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: The ECOG experience. The Eastern Cooperative Oncology Group. Leukemia 6:116, 1992 (suppl 2)
163. Burnett AK, Goldstone AH, Stevens RMF, Hann IM, Gray RG, Rees JKH, Wheatley KW: Randomised comparison of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC-AML 10 trial. Lancet 351:700, 1998
164. Suciu S, on behalf of the AML collaborative group of EORTC: Meta-analysis of randomized trials comparing autologous BMT ( ABMT) vs chemotherapy (CT) or ABMT vs no further treatment (NFT) as post remission treatment in adult AML patients. Bone Marrow Transplant 21:43a, 1998
165. Welch HG, Larson EB: Cost effectiveness of bone marrow transplantation in acute non lymphocytic leukemia. N Engl J Med 321:807, 1989
166. Dufoir T, Saux MC, Terraza B, Marit G, Guessard S, Foulon G, Reiffers J: Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission. Bone Marrow Transplant 10:323, 1992
167. Swedish Council on Technology Assessment in Health Care; Benmargs-transplantation. Stockholm, Sweden, SBU, 1991